vs
DENNY'S Corp（DENN）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是DENNY'S Corp的1.9倍（$219.9M vs $113.2M），DENNY'S Corp净利率更高（0.6% vs -1.0%，领先1.6%），Orthofix Medical Inc.同比增速更快（2.0% vs 1.3%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $16.0M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -0.9%）
丹尼氏是源自美国的堂食美式连锁餐吧品牌，目前在全球多个国家和地区开展业务，仅在美国、加拿大、墨西哥、波多黎各等地就运营着超过1400家门店，主打轻松随性的美式正餐用餐体验。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DENN vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.9倍
$113.2M
营收增速更快
OFIX
高出0.6%
1.3%
净利率更高
DENN
高出1.6%
-1.0%
自由现金流更多
OFIX
多$869.0K
$16.0M
两年增速更快
OFIX
近两年复合增速
-0.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $113.2M | $219.9M |
| 净利润 | $632.0K | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 9.2% | 0.2% |
| 净利率 | 0.6% | -1.0% |
| 营收同比 | 1.3% | 2.0% |
| 净利润同比 | -90.3% | 92.4% |
| 每股收益（稀释后） | $0.01 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DENNOFIX
| Q4 25 | — | $219.9M | ||
| Q3 25 | $113.2M | $205.6M | ||
| Q2 25 | $117.7M | $203.1M | ||
| Q1 25 | $111.6M | $193.6M | ||
| Q4 24 | $114.7M | $215.7M | ||
| Q3 24 | $111.8M | $196.6M | ||
| Q2 24 | $115.9M | $198.6M | ||
| Q1 24 | $110.0M | $188.6M |
净利润DENNOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $632.0K | $-22.8M | ||
| Q2 25 | $2.5M | $-14.1M | ||
| Q1 25 | $326.0K | $-53.1M | ||
| Q4 24 | $6.8M | $-29.1M | ||
| Q3 24 | $6.5M | $-27.4M | ||
| Q2 24 | $3.6M | $-33.4M | ||
| Q1 24 | $4.7M | $-36.0M |
毛利率DENNOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率DENNOFIX
| Q4 25 | — | 0.2% | ||
| Q3 25 | 9.2% | -8.3% | ||
| Q2 25 | 7.3% | -7.9% | ||
| Q1 25 | 4.7% | -25.2% | ||
| Q4 24 | 12.6% | -5.3% | ||
| Q3 24 | 10.5% | -9.6% | ||
| Q2 24 | 7.9% | -12.5% | ||
| Q1 24 | 9.1% | -15.6% |
净利率DENNOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | 0.6% | -11.1% | ||
| Q2 25 | 2.1% | -6.9% | ||
| Q1 25 | 0.3% | -27.4% | ||
| Q4 24 | 5.9% | -13.5% | ||
| Q3 24 | 5.8% | -13.9% | ||
| Q2 24 | 3.1% | -16.8% | ||
| Q1 24 | 4.3% | -19.1% |
每股收益（稀释后）DENNOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $0.01 | $-0.57 | ||
| Q2 25 | $0.05 | $-0.36 | ||
| Q1 25 | $0.01 | $-1.35 | ||
| Q4 24 | $0.13 | $-0.76 | ||
| Q3 24 | $0.12 | $-0.71 | ||
| Q2 24 | $0.07 | $-0.88 | ||
| Q1 24 | $0.09 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-32.7M | $450.0M |
| 总资产 | $502.9M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DENNOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | $1.1M | $58.0M | ||
| Q4 24 | $100.0K | $83.2M | ||
| Q3 24 | $2.9M | $30.1M | ||
| Q2 24 | $2.8M | $26.4M | ||
| Q1 24 | $2.8M | $27.0M |
总债务DENNOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $270.6M | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益DENNOFIX
| Q4 25 | — | $450.0M | ||
| Q3 25 | $-32.7M | $442.5M | ||
| Q2 25 | $-34.6M | $458.3M | ||
| Q1 25 | $-36.4M | $458.3M | ||
| Q4 24 | $-34.0M | $503.1M | ||
| Q3 24 | $-54.5M | $525.9M | ||
| Q2 24 | $-53.2M | $546.0M | ||
| Q1 24 | $-55.7M | $570.3M |
总资产DENNOFIX
| Q4 25 | — | $850.6M | ||
| Q3 25 | $502.9M | $832.6M | ||
| Q2 25 | $491.1M | $837.2M | ||
| Q1 25 | $488.1M | $823.1M | ||
| Q4 24 | $496.3M | $893.3M | ||
| Q3 24 | $461.6M | $867.9M | ||
| Q2 24 | $459.9M | $882.0M | ||
| Q1 24 | $460.4M | $906.0M |
负债/权益比DENNOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 14.1% | 7.6% |
| 资本支出强度资本支出/营收 | 0.0% | 4.9% |
| 现金转化率经营现金流/净利润 | 25.28× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DENNOFIX
| Q4 25 | — | $27.7M | ||
| Q3 25 | $16.0M | $12.4M | ||
| Q2 25 | $9.4M | $11.6M | ||
| Q1 25 | $5.0M | $-18.4M | ||
| Q4 24 | $8.5M | $23.7M | ||
| Q3 24 | $6.6M | $11.7M | ||
| Q2 24 | $14.2M | $9.0M | ||
| Q1 24 | $215.0K | $-18.6M |
自由现金流DENNOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | $16.0M | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率DENNOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | 14.1% | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度DENNOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | 0.0% | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | 0.0% | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率DENNOFIX
| Q4 25 | — | — | ||
| Q3 25 | 25.28× | — | ||
| Q2 25 | 3.79× | — | ||
| Q1 25 | 15.38× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 3.97× | — | ||
| Q1 24 | 0.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
